The invention relates to 6-substituted isoquinoline and isochinolone derivativesof the formula (I) useful for the treatment and/or prevention of diseases associatedwith Rho-kinase and/or Rho-kinase mediated phosphorylation of myosin lightchain phosphatase, and compositions containing such compounds.